PhD - Biotechnology (Therapeutics) - Antibody therapy for an important equine disease


An opportunity is available for a suitable candidate to undertake PhD research as part of an Australian Research Council funded Linkage project. This large multicentre project involves researchers at three Australian universities and a commercial biotechnology company partner, Nexvet. The project objective is to design and develop a novel investigational antibody therapy for the treatment of a common and serious condition of horses and ponies, for which there are currently no approved biologic therapies. 

Commencing in February, the student will be enrolled at the University of Melbourne but will be based primarily at La Trobe’s Bundoora campus in the laboratories of Nexvet, a company that is at the forefront of developing new biologic therapies for the treatment of veterinary diseases.The Melbourne team will also collaborate with our research partners at Queensland University of Technology and The University of Queensland in Brisbane. 

This is a unique opportunity to be involved in the process of designing and developing a new biological therapy within a pioneering biotech company, and will provide excellent experience for anyone interested in working in the biotechnology field. It would suit a student with interests in molecular/cell biology and protein chemistry, particularly if they are also interested in the areas of growth factors and biological therapeutics (and perhaps also horses!). 

How to apply

Please contact Simon Bailey directly to discuss your application.


A/Prof. Simon Bailey, Faculty of Veterinary and Agricultural Sciences 
University of Melbourne 
T: 03 8344 6315 | E: